Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction



Status:Completed
Conditions:Ovarian Cancer, Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:21 - 120
Updated:4/21/2016
Start Date:November 2007
End Date:December 2012

Use our guide to learn which trials are right for you!

Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.

RATIONALE: Studying samples of exhaled breath from patients with ovarian epithelial cancer,
polycystic ovarian syndrome, or endometriosis and from healthy participants in the
laboratory may help doctors identify and learn more about biomarkers related to cancer. It
may also help doctors find and diagnose ovarian epithelial cancer sooner, when it may be
easier to treat.

PURPOSE: This clinical trial is studying exhaled breath biomarkers to see how well they find
ovarian epithelial cancer in patients with newly diagnosed ovarian epithelial cancer,
polycystic ovarian syndrome, or endometriosis and in healthy participants.

OBJECTIVES:

- Identify patterns of exhaled compounds in breath samples from patients with newly
diagnosed ovarian epithelial cancer that are significantly and reproducibility
different from those of healthy volunteers using gas chromatography Fourier transform
ion cyclotron resonance mass spectrometry (GC/FT-ICR MS).

- Train five canines to discriminate between exhaled breath samples from patients with
newly diagnosed ovarian epithelial cancer and healthy volunteers.

- Use both canine olfaction and GC/FT-ICR MS to distinguish between exhaled breath
samples from patients with newly diagnosed ovarian epithelial cancer and patients with
polycystic ovarian syndrome or endometriosis.

- Repeat breath sampling in patients with newly diagnosed ovarian epithelial cancer
throughout the course of diagnosis and therapy.

OUTLINE: Exhaled breath samples are collected from patients and healthy volunteers. The
samples are analyzed by gas chromatography Fourier transform ion cyclotron resonance mass
spectrometry (GC/FT-ICR MS) to determine chemical compositions, identities, and predictive
patterns of biomarkers in exhaled breath condensate. GC/FT-ICR MS and trained canine
olfaction are used to distinguish between exhaled breath samples from patients with ovarian
epithelial cancer, patients with polycystic ovarian syndrome or endometriosis, and healthy
volunteers.

Patients and healthy volunteers complete questionnaires about BRCA 1 and BRCA 2 status (if
known), alcohol use, smoking (including duration and type of cigarettes), physical activity
(duration and type), socioeconomic status, education, county of residence, age at menopause
(if applicable), age at menarche, presence of first- and second-degree family history of
breast cancer or ovarian epithelial cancer, body mass index (height and weight), and
co-morbidities.

DISEASE CHARACTERISTICS:

- Meets one of the following criteria:

- Histologically confirmed ovarian epithelial cancer

- Newly diagnosed disease

- Diagnosis of polycystic ovarian syndrome or endometriosis

- Healthy volunteer meeting all of the following criteria:

- No prior ovarian cancer (including invasive ovarian epithelial cancer,
fallopian tube cancer, or primary papillary serous carcinoma of the
peritoneum)

- No prior breast cancer (including ductal carcinoma in situ [DCIS])

- No prior ovarian or breast cancer (including DCIS) in any first- or
second-degree relative

- BRCA1 or BRCA2 mutation negative (if known) OR no first- or second-degree
relative with a BRCA1 or BRCA2 mutation (if known)

- No prior diagnosis of cancer

PATIENT CHARACTERISTICS:

- Lives in California and close to the study sampling centers

- Reads and writes English, Spanish, or Chinese

- Non-smoker

- Willing to provide breath samples

- No alcohol intake within the past 3 days

PRIOR CONCURRENT THERAPY:

- At least 3 days since prior Cox-2 inhibitors, vitamin E, omega-3 fatty acids,
antioxidants, bromelain, coenzyme Q10, curcumin, or vitamin A
We found this trial at
4
sites
Orono, Maine 04469
?
mi
from
Orono, ME
Click here to add this to my saved trials
1600 Divisadero Street
San Francisco, California 94115
888.689.8273
UCSF Helen Diller Family Comprehensive Cancer Center UCSF’s long tradition of excellence in cancer research...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
San Anselmo, California 94960
?
mi
from
San Anselmo, CA
Click here to add this to my saved trials
3700 California Street
San Francisco, California 94118
(415) 600-6000
California Pacific Medical Center - California Campus California Pacific Medical Center is one of the...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials